Search

Your search keyword '"Herzka, Tali M."' showing total 2 results
Start Over Author "Herzka, Tali M." Publication Type Academic Journals
2 results on '"Herzka, Tali M."'

1. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

Author

Muhan Chen, Nowak, Dawid G., Narula, Navneet, Robinson, Brian, Watrud, Kaitlin, Ambrico, Alexandra, Herzka, Tali M., Zeeman, Martha E., Minderer, Matthias, Wu Zheng, Ebbesen, Saya H., Plafker, Kendra S., Stahlhut, Carlos, Victoria M.y. Wang, Wills, Lorna, Nasar, Abu, Castillo-Martin, Mireia, Cordon-Cardo, Carlos, Wilkinson, John E., and Powers, Scott

Subjects
*PTEN protein, *TUMOR suppressor proteins
Abstract

Phosphatase and tensin homologue (PTEN) protein levels are critical for tumor suppression. However, the search for a recurrent cancer-associated gene alteration that causes PTEN degradation has remained futile. In this study, we show that Importin-11 (Ipo11) is a transport receptor for PTEN that is required to physically separate PTEN from elements of the PTEN degradation machinery. Mechanistically, we find that the E2 ubiquitin-conjugating enzyme and IPO11 cargo, UBE2E1, is a limiting factor for PTEN degradation. Using in vitro and in vivo gene-targeting methods, we show that Ipo11 loss results in degradation of Pten, lung adenocarcinoma, and neoplasia in mouse prostate with aberrantly high levels of Ube2e1 in the cytoplasm. These findings explain the correlation between loss of IPO11 and PTEN protein in human lung tumors. Furthermore, we find that IPO11 status predicts disease recurrence and progression to metastasis in patients choosing radical prostatectomy. Thus, our data introduce the IPO11 gene as a tumor-suppressor locus, which is of special importance in cancers that still retain at least one intact PTEN allele. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

2. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

Author

Chen M, Nowak DG, Narula N, Robinson B, Watrud K, Ambrico A, Herzka TM, Zeeman ME, Minderer M, Zheng W, Ebbesen SH, Plafker KS, Stahlhut C, Wang VM, Wills L, Nasar A, Castillo-Martin M, Cordon-Cardo C, Wilkinson JE, Powers S, Sordella R, Altorki NK, Mittal V, Stiles BM, Plafker SM, and Trotman LC

Subjects
Animals, Cell Line, Cell Line, Tumor, Cell Nucleus metabolism, Cytoplasm metabolism, HeLa Cells, Humans, Lung Neoplasms metabolism, Mice, Ubiquitin-Conjugating Enzymes metabolism, PTEN Phosphohydrolase metabolism, Receptors, Cytoplasmic and Nuclear metabolism, Tumor Suppressor Proteins metabolism, beta Karyopherins metabolism
Abstract

Phosphatase and tensin homologue (PTEN) protein levels are critical for tumor suppression. However, the search for a recurrent cancer-associated gene alteration that causes PTEN degradation has remained futile. In this study, we show that Importin-11 (Ipo11) is a transport receptor for PTEN that is required to physically separate PTEN from elements of the PTEN degradation machinery. Mechanistically, we find that the E2 ubiquitin-conjugating enzyme and IPO11 cargo, UBE2E1, is a limiting factor for PTEN degradation. Using in vitro and in vivo gene-targeting methods, we show that Ipo11 loss results in degradation of Pten, lung adenocarcinoma, and neoplasia in mouse prostate with aberrantly high levels of Ube2e1 in the cytoplasm. These findings explain the correlation between loss of IPO11 and PTEN protein in human lung tumors. Furthermore, we find that IPO11 status predicts disease recurrence and progression to metastasis in patients choosing radical prostatectomy. Thus, our data introduce the IPO11 gene as a tumor-suppressor locus, which is of special importance in cancers that still retain at least one intact PTEN allele., (© 2017 Chen et al.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results